Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468)

Keisuke Izumi; Yuko Kaneko; Misato Hashizume; Keiko Yoshimoto; Tsutomu Takeuchi

doi:10.1371/journal.pone.0152341

Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468)

Keisuke Izumi
, Yuko Kaneko
, Misato Hashizume
, Keiko Yoshimoto
, Tsutomu Takeuchi

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	e0152341
Journal	PloS one
Volume	11
Issue number	3
DOIs	https://doi.org/10.1371/journal.pone.0152341
Publication status	Published - 2016 Mar

ASJC Scopus subject areas

General

Access to Document

10.1371/journal.pone.0152341

Cite this

Izumi, K., Kaneko, Y., Hashizume, M., Yoshimoto, K., & Takeuchi, T. (2016). Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468). PloS one, 11(3), Article e0152341. https://doi.org/10.1371/journal.pone.0152341

Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468). / Izumi, Keisuke; Kaneko, Yuko; Hashizume, Misato et al.
In: PloS one, Vol. 11, No. 3, e0152341, 03.2016.

Research output: Contribution to journal › Comment/debate › peer-review

Izumi, K, Kaneko, Y, Hashizume, M, Yoshimoto, K & Takeuchi, T 2016, 'Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468)', PloS one, vol. 11, no. 3, e0152341. https://doi.org/10.1371/journal.pone.0152341

Izumi K, Kaneko Y, Hashizume M, Yoshimoto K, Takeuchi T. Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468). PloS one. 2016 Mar;11(3):e0152341. doi: 10.1371/journal.pone.0152341

Izumi, Keisuke ; Kaneko, Yuko ; Hashizume, Misato et al. / Erratum : Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468). In: PloS one. 2016 ; Vol. 11, No. 3.

@article{739def8f733a4e5d8173c952c62f609e,

title = "Erratum: Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Na{\"i}ve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468)",

author = "Keisuke Izumi and Yuko Kaneko and Misato Hashizume and Keiko Yoshimoto and Tsutomu Takeuchi",

year = "2016",

month = mar,

doi = "10.1371/journal.pone.0152341",

language = "English",

volume = "11",

journal = "PloS one",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "3",

}

TY - JOUR

T1 - Erratum

T2 - Baseline serum osteopontin levels predict the clinical effectiveness of tocilizumab but not infliximab in biologic-Naïve patients with rheumatoid arthritis: A single-center prospective study at 1 year (the Keio First-Bio Cohort Study) (PLo SONE (2015) 10:12 (e0145468) DOI:10.1371/journal.pone.0145468)

AU - Izumi, Keisuke

AU - Kaneko, Yuko

AU - Hashizume, Misato

AU - Yoshimoto, Keiko

AU - Takeuchi, Tsutomu

PY - 2016/3

Y1 - 2016/3

UR - https://www.scopus.com/pages/publications/84962119042

UR - https://www.scopus.com/pages/publications/84962119042#tab=citedBy

U2 - 10.1371/journal.pone.0152341

DO - 10.1371/journal.pone.0152341

M3 - Comment/debate

AN - SCOPUS:84962119042

SN - 1932-6203

VL - 11

JO - PloS one

JF - PloS one

IS - 3

M1 - e0152341

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this